- Report
- May 2026
- 100 Pages
Global
From €2491EUR$2,699USD£2,086GBP
- Report
- May 2026
- 100 Pages
Global
From €2491EUR$2,699USD£2,086GBP
- Report
- March 2026
- 150 Pages
Global
From €2491EUR$2,699USD£2,086GBP
- Report
- March 2026
- 200 Pages
Global
From €2574EUR$2,789USD£2,155GBP
- Report
- April 2026
- 135 Pages
Global
From €3691EUR$3,999USD£3,090GBP
- Report
- August 2026
- 111 Pages
Global
From €4384EUR$4,750USD£3,670GBP
- Report
- August 2026
- 115 Pages
Global
From €4384EUR$4,750USD£3,670GBP
- Report
- August 2026
- 136 Pages
Global
From €4384EUR$4,750USD£3,670GBP
- Report
- July 2026
- 185 Pages
Global
From €4384EUR$4,750USD£3,670GBP
- Report
- April 2026
- 110 Pages
Global
From €4384EUR$4,750USD£3,670GBP
- Report
- January 2026
- 140 Pages
Global
From €3645EUR$3,950USD£3,052GBP
- Report
- August 2026
- 160 Pages
Global
From €3064EUR$3,320USD£2,565GBP
€3830EUR$4,150USD£3,207GBP
- Report
- July 2026
- 160 Pages
Global
From €3064EUR$3,320USD£2,565GBP
€3830EUR$4,150USD£3,207GBP
- Report
- April 2026
- 160 Pages
Global
From €3064EUR$3,320USD£2,565GBP
€3830EUR$4,150USD£3,207GBP
- Report
- April 2026
- 160 Pages
Global
From €3064EUR$3,320USD£2,565GBP
€3830EUR$4,150USD£3,207GBP
- Report
- April 2026
- 160 Pages
Global
From €3064EUR$3,320USD£2,565GBP
€3830EUR$4,150USD£3,207GBP
- Report
- April 2026
- 160 Pages
Global
From €3064EUR$3,320USD£2,565GBP
€3830EUR$4,150USD£3,207GBP
- Report
- July 2026
- 218 Pages
Global
From €3500EUR$4,062USD£3,033GBP
- Report
- October 2026
- 384 Pages
Global
From €5399EUR$5,850USD£4,520GBP
- Report
- March 2026
- 130 Pages
Global
From €4476EUR$4,850USD£3,748GBP

Anticonvulsants are a class of drugs used to treat seizures and other neurological disorders. They work by reducing the abnormal electrical activity in the brain that causes seizures. Anticonvulsants are used to treat a variety of conditions, including epilepsy, bipolar disorder, and neuropathic pain. They are also used to prevent seizures in people with certain types of brain injuries. Anticonvulsants are part of the larger class of Central Nervous System (CNS) drugs, which also includes antidepressants, antipsychotics, and anxiolytics.
The anticonvulsant market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, GlaxoSmithKline, Novartis, Sanofi, and Johnson & Johnson. Other companies include Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more